Glanbia
Glanbia plc operates as a nutrition company worldwide. The last earnings update was 84 days ago. More info.
Add to Portfolio Compare Print
GL9 Share Price and Events
7 Day Returns
1 Year Returns
GL9 Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Glanbia (GL9) | -2.3% | -6.7% | -11.2% | 6.7% | -4.3% | 41.8% |
| Europe Food | 1.6% | 2.7% | 7.3% | 10.6% | 13.2% | 39.4% |
| IE Market | -0% | -5.3% | 1.6% | -13.6% | 0.7% | 39.8% |
1 Year Return vs Industry and Market
- GL9 underperformed the Food industry which returned 10.6% over the past year.
- GL9 outperformed the Market in Ireland which returned -13.6% over the past year.
Value
Is Glanbia undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Glanbia
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Glanbia.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 9 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 6.6% |
| Perpetual Growth Rate | 10-Year IE Government Bond Rate | 0.9% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year IE Govt Bond Rate | 0.9% |
| Equity Risk Premium | S&P Global | 7.1% |
| Food Unlevered Beta | Simply Wall St/ S&P Global | 0.54 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.544 (1 + (1- 12.5%) (17.26%)) |
0.75 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.8 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.9% + (0.8 * 7.14%) |
6.61% |
Discounted Cash Flow Calculation for ISE:GL9 using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Glanbia is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (EUR, Millions) | Source |
Present Value Discounted (@ 6.61%) |
|
|---|---|---|---|
| 2019 | 206.76 | Analyst x5 | 193.94 |
| 2020 | 272.14 | Analyst x5 | 239.43 |
| 2021 | 291.20 | Analyst x5 | 240.31 |
| 2022 | 305.79 | Est @ 5.01% | 236.70 |
| 2023 | 317.34 | Est @ 3.78% | 230.41 |
| 2024 | 326.58 | Est @ 2.91% | 222.41 |
| 2025 | 334.13 | Est @ 2.31% | 213.44 |
| 2026 | 340.43 | Est @ 1.89% | 203.98 |
| 2027 | 345.85 | Est @ 1.59% | 194.37 |
| 2028 | 350.63 | Est @ 1.38% | 184.84 |
| Present value of next 10 years cash flows | €2,159.82 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= €350.63 × (1 + 0.9%) ÷ (6.61% – 0.9%) |
€6,193.77 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= €6,193.77 ÷ (1 + 6.61%)10 |
€3,265.08 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= €2,159.82 + €3,265.08 |
€5,424.90 |
| Equity Value per Share (EUR) |
= Total value / Shares Outstanding
= €5,424.90 / 295.17 |
€18.38 |
| Calculation | Result | |
|---|---|---|
| Value per share (EUR) | From above. | €18.38 |
| Current discount | Discount to share price of
€15.85
= -1 x (€15.85 - €18.38) / €18.38 |
13.8% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Glanbia's share price is below the future cash flow value, but not at a moderate discount (< 20%).
- Glanbia's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Glanbia's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Glanbia's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-29) in EUR | €0.79 |
| ISE:GL9 Share Price ** | ISE (2019-05-22) in EUR | €15.85 |
| Europe Food Industry PE Ratio | Median Figure of 120 Publicly-Listed Food Companies | 17.89x |
| Ireland Market PE Ratio | Median Figure of 23 Publicly-Listed Companies | 11.42x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Glanbia.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = ISE:GL9 Share Price ÷ EPS (both in EUR) = 15.85 ÷ 0.79 |
19.99x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Glanbia is overvalued based on earnings compared to the Europe Food industry average.
- Glanbia is overvalued based on earnings compared to the Ireland market.
Price based on expected Growth
Does
Glanbia's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 19.99x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts |
7.3%per year |
| Europe Food Industry PEG Ratio | Median Figure of 67 Publicly-Listed Food Companies | 1.76x |
| Ireland Market PEG Ratio | Median Figure of 19 Publicly-Listed Companies | 0.99x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 19.99x ÷ 7.3% |
2.75x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Glanbia is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Glanbia's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-29) in EUR | €5.38 |
| ISE:GL9 Share Price * | ISE (2019-05-22) in EUR | €15.85 |
| Europe Food Industry PB Ratio | Median Figure of 160 Publicly-Listed Food Companies | 1.27x |
| Ireland Market PB Ratio | Median Figure of 33 Publicly-Listed Companies | 1.15x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = ISE:GL9 Share Price ÷ Book Value per Share (both in EUR) = 15.85 ÷ 5.38 |
2.94x |
* Primary Listing of Glanbia.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Glanbia is overvalued based on assets compared to the Europe Food industry average.
Value checks
We assess Glanbia's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Food industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Food industry average (and greater than 0)? (1 check) Glanbia has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
How is Glanbia expected to perform in the next 1 to 3 years based on estimates from 9 analysts?
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Glanbia's earnings growth is expected to exceed the low risk savings rate of 0.9%.
Growth vs Market Checks
- Glanbia's earnings growth is positive but not above the Ireland market average.
- Glanbia's revenue growth is expected to exceed the Ireland market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| ISE:GL9 Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts | 7.3% |
| ISE:GL9 Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts | 10% |
| Europe Food Industry Earnings Growth Rate | Market Cap Weighted Average | 10.7% |
| Europe Food Industry Revenue Growth Rate | Market Cap Weighted Average | 4.1% |
| Ireland Market Earnings Growth Rate | Market Cap Weighted Average | 11.9% |
| Ireland Market Revenue Growth Rate | Market Cap Weighted Average | 5.2% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (4 months ago) | See Below |
| Future Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
| Date (Data in EUR Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 4,272 | 2 | ||
| 2022-12-31 | 4,093 | 307 | 3 | |
| 2021-12-31 | 4,004 | 361 | 292 | 6 |
| 2020-12-31 | 3,811 | 335 | 270 | 9 |
| 2019-12-31 | 3,637 | 248 | 246 | 9 |
| 2018-12-31 | 2,357 | 266 | 225 | 8 |
| Date (Data in EUR Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-29 | 2,386 | 275 | 234 |
| 2018-09-29 | 2,350 | 251 | 226 |
| 2018-06-30 | 2,313 | 227 | 219 |
| 2018-03-31 | 2,350 | 159 | 228 |
| 2017-12-30 | 2,387 | 91 | 237 |
| 2017-09-30 | 2,363 | 148 | 223 |
| 2017-07-01 | 2,340 | 205 | 210 |
| 2017-04-01 | 2,286 | 264 | 199 |
| 2016-12-31 | 2,232 | 323 | 188 |
| 2016-09-30 | 2,326 | 308 | 183 |
| 2016-07-02 | 2,421 | 293 | 179 |
| 2016-04-02 | 2,597 | 285 | 181 |
| 2016-01-02 | 2,774 | 277 | 183 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (4 months ago) | See Below |
| Future Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
All data from Glanbia Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in EUR Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | ||||
| 2022-12-31 | 1.04 | 1.04 | 1.04 | 1.00 |
| 2021-12-31 | 1.03 | 1.16 | 0.95 | 6.00 |
| 2020-12-31 | 0.94 | 1.08 | 0.88 | 8.00 |
| 2019-12-31 | 0.87 | 0.99 | 0.81 | 8.00 |
| 2018-12-31 | 0.76 | 0.78 | 0.74 | 6.00 |
| Date (Data in EUR Millions) | EPS * |
|---|---|
| 2018-12-29 | 0.79 |
| 2018-09-29 | 0.77 |
| 2018-06-30 | 0.74 |
| 2018-03-31 | 0.77 |
| 2017-12-30 | 0.80 |
| 2017-09-30 | 0.76 |
| 2017-07-01 | 0.71 |
| 2017-04-01 | 0.67 |
| 2016-12-31 | 0.64 |
| 2016-09-30 | 0.62 |
| 2016-07-02 | 0.61 |
| 2016-04-02 | 0.61 |
| 2016-01-02 | 0.62 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Glanbia's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Glanbia has a total score of 2/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Glanbia performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Glanbia's year on year earnings growth rate has been positive over the past 5 years.
- Glanbia's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Glanbia's 1-year earnings growth is negative, it can't be compared to the Europe Food industry average.
Earnings and Revenue History
All data from Glanbia Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in EUR Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-29 | 2,386.30 | 234.00 | 395.20 | |
| 2018-09-29 | 2,349.85 | 226.45 | 373.70 | |
| 2018-06-30 | 2,313.40 | 218.90 | 352.20 | |
| 2018-03-31 | 2,350.25 | 228.05 | 356.85 | |
| 2017-12-30 | 2,387.10 | 237.20 | 361.50 | |
| 2017-09-30 | 2,363.34 | 223.44 | 454.20 | |
| 2017-07-01 | 2,339.59 | 209.67 | 546.90 | |
| 2017-04-01 | 2,285.64 | 198.69 | 454.10 | |
| 2016-12-31 | 2,231.70 | 187.70 | 361.30 | |
| 2016-09-30 | 2,326.12 | 183.41 | 394.18 | |
| 2016-07-02 | 2,420.55 | 179.12 | 427.06 | |
| 2016-04-02 | 2,597.44 | 181.20 | 427.06 | |
| 2016-01-02 | 2,774.33 | 183.27 | 427.06 | |
| 2015-10-02 | 2,725.06 | 172.33 | 343.67 | 3.92 |
| 2015-07-04 | 2,675.80 | 161.40 | 260.29 | 7.83 |
| 2015-04-04 | 2,607.08 | 153.85 | 260.29 | 7.83 |
| 2015-01-03 | 2,538.37 | 146.31 | 260.29 | 7.83 |
| 2014-10-03 | 2,489.15 | 149.75 | 247.30 | 7.78 |
| 2014-07-05 | 2,439.94 | 153.18 | 234.32 | 7.72 |
| 2014-04-05 | 2,411.04 | 151.76 | 234.32 | 7.72 |
| 2014-01-04 | 2,382.13 | 150.33 | 234.32 | 7.72 |
| 2013-10-04 | 2,366.10 | 141.86 | 216.22 | 8.56 |
| 2013-06-29 | 2,350.07 | 133.38 | 198.11 | 9.39 |
| 2013-03-29 | 2,280.91 | 129.48 | 198.89 | 9.39 |
| 2012-12-29 | 2,211.76 | 125.58 | 199.67 | 9.39 |
| 2012-06-30 | 1,687.95 | 90.64 | 38.22 | 8.40 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Glanbia has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Glanbia used its assets more efficiently than the Europe Food industry average last year based on Return on Assets.
- Glanbia's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Glanbia's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Food industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Glanbia has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Glanbia's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Glanbia's finances.
The net worth of a company is the difference between its assets and liabilities.
- Glanbia is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Glanbia's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Glanbia Company Filings, last reported 4 months ago.
| Date (Data in EUR Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-29 | 1,589.10 | 801.30 | 224.60 |
| 2018-09-29 | 1,589.10 | 801.30 | 224.60 |
| 2018-06-30 | 1,461.60 | 551.90 | 149.80 |
| 2018-03-31 | 1,461.60 | 551.90 | 149.80 |
| 2017-12-30 | 1,381.70 | 529.90 | 162.20 |
| 2017-09-30 | 1,381.70 | 529.90 | 162.20 |
| 2017-07-01 | 1,249.56 | 902.73 | 129.31 |
| 2017-04-01 | 1,249.56 | 902.73 | 129.31 |
| 2016-12-31 | 1,227.10 | 656.40 | 218.90 |
| 2016-09-30 | 1,227.10 | 656.40 | 218.90 |
| 2016-07-02 | 1,060.65 | 739.25 | 94.91 |
| 2016-04-02 | 1,060.65 | 739.25 | 94.91 |
| 2016-01-02 | 1,063.07 | 795.13 | 210.89 |
| 2015-10-02 | 1,063.07 | 795.13 | 210.89 |
| 2015-07-04 | 980.72 | 671.46 | 94.40 |
| 2015-04-04 | 980.72 | 671.46 | 94.40 |
| 2015-01-03 | 804.78 | 620.73 | 110.37 |
| 2014-10-03 | 804.78 | 620.73 | 110.37 |
| 2014-07-05 | 695.92 | 560.78 | 89.01 |
| 2014-04-05 | 695.92 | 560.78 | 89.01 |
| 2014-01-04 | 643.52 | 480.70 | 106.26 |
| 2013-10-04 | 643.52 | 480.70 | 106.26 |
| 2013-06-29 | 622.48 | 517.75 | 73.06 |
| 2013-03-29 | 622.48 | 517.75 | 73.06 |
| 2012-12-29 | 544.66 | 652.13 | 275.57 |
| 2012-06-30 | 541.61 | 725.74 | 164.45 |
- Glanbia's level of debt (50.4%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (74.7% vs 50.4% today).
- Debt is well covered by operating cash flow (34.3%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 15.4x coverage).
Financial health checks
We assess Glanbia's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Glanbia has a total score of 4/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Glanbia's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
€2,000 of
Glanbia
shares you are expected to receive
€31
in your first year as a dividend.
Dividend Amount
- Glanbia's pays a lower dividend yield than the bottom 25% of dividend payers in Ireland (2.18%).
- Glanbia's dividend is below the markets top 25% of dividend payers in Ireland (4.07%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
| Europe Food Industry Average Dividend Yield | Market Cap Weighted Average of 97 Stocks | 2.4% |
| Ireland Market Average Dividend Yield | Market Cap Weighted Average of 21 Stocks | 2.4% |
| Ireland Minimum Threshold Dividend Yield | 10th Percentile | 1.2% |
| Ireland Bottom 25% Dividend Yield | 25th Percentile | 2.2% |
| Ireland Top 25% Dividend Yield | 75th Percentile | 4.1% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in €) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | ||
| 2022-12-31 | 0.35 | 1.00 |
| 2021-12-31 | 0.33 | 7.00 |
| 2020-12-31 | 0.29 | 10.00 |
| 2019-12-31 | 0.27 | 10.00 |
| 2018-12-31 | 0.25 | 9.00 |
| Date (Data in €) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-04-24 | 0.242 | 1.503 |
| 2018-02-21 | 0.220 | 1.423 |
| 2017-02-22 | 0.133 | 0.808 |
| 2016-03-03 | 0.121 | 0.730 |
| 2016-02-24 | 0.121 | 0.652 |
| 2015-04-09 | 0.110 | 0.632 |
| 2015-02-25 | 0.110 | 0.651 |
| 2014-03-12 | 0.100 | 0.850 |
| 2014-03-11 | 0.100 | 0.901 |
| 2013-03-13 | 0.091 | 0.889 |
| 2012-04-05 | 0.083 | 1.216 |
| 2012-02-29 | 0.083 | 1.440 |
| 2011-08-24 | 0.078 | 1.687 |
| 2011-03-02 | 0.075 | 1.677 |
| 2011-03-01 | 0.075 | 1.749 |
| 2010-04-19 | 0.068 | 2.020 |
| 2010-03-10 | 0.068 | 2.379 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Whilst dividend payments have been stable, Glanbia has been paying a dividend for less than 10 years.
- Dividend payments have increased, but Glanbia only paid a dividend in the past 9 years.
Income/ dividend checks
We assess Glanbia's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Glanbia afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Glanbia has a total score of 2/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| COMPENSATION | €2,341,000 |
| AGE | 54 |
| TENURE AS CEO | 5.5 years |
CEO Bio
Ms. Siobhán Talbot, B.Comm., FCA has been the Group Managing Director of Glanbia plc since November 12, 2013 and its Executive Director since July 1, 2009. Ms. Talbot served as Group Finance Director at Glanbia plc from March 2009 to November 2013. She served as Deputy Group Finance Director at Glanbia Plc from June 2005 to March 2009 and served as its Group Secretary from 2000 to June 2005. She served in number of Senior Positions in Finance since she joined the Group in 1992 and Group Operations Controller since 2000. She has been Non-Executive Director of CRH PLC since December 1, 2018. She is also a Director of the Irish Business Employers Confederation (IBEC). Ms. Talbot is a fellow of Chartered Accountants Ireland. Ms. Talbot graduated from University College Dublin with a Bachelor of Commerce and Diploma in Professional Accounting. She was previously trained and worked with Price Waterhouse in Dublin and Sydney, Australia.
CEO Compensation
- Siobhán's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.
- Siobhán's remuneration is higher than average for companies of similar size in Ireland.
Management Team Tenure
Average tenure and age of the Glanbia management team in years:
- The tenure for the Glanbia management team is about average.
Management Team
Siobhán Talbot
Group MD & Executive Director
€2M
54
5.5 yrs
Mark Garvey
Group Finance Director & Executive Director
€1M
54
5.5 yrs
Brian Phelan
Chief Executive Officer of Glanbia Nutritionals
€1M
51
0.3 yrs
Hugh McGuire
Chief Executive Officer of Glanbia Performance Nutrition
€1M
47
0.3 yrs
Liam Hennigan
Group Director of Strategic Planning & Investor Relations
Martha Kavanagh
Head of Corporate Communications
Tom Tench
Group Corporate Development Director
47
4.2 yrs
Michael Patten
Director of Group Human Resources & Corporate Affairs
56
4.4 yrs
Michael Horan
Group Secretary
53
13.9 yrs
Jim Bergin
Chief Executive of Glanbia Ingredients Ireland Limited
55
1.8 yrs
Board of Directors Tenure
Average tenure and age of the Glanbia board of directors in years:
- The average tenure for the Glanbia board of directors is less than 3 years, this suggests a new board.
Board of Directors
Martin Keane
Chairman
€90K
62
0.9 yrs
Siobhán Talbot
Group MD & Executive Director
€2M
54
9.8 yrs
John Murphy
Vice Chairman
€60K
55
1.9 yrs
Patrick Murphy
Vice Chairman
€53K
60
0.9 yrs
Mark Garvey
Group Finance Director & Executive Director
€1M
54
5.5 yrs
Donard Gaynor
Independent Non-Executive Director
€95K
61
6.2 yrs
Dan O'Connor
Senior Independent Director
€95K
58
Michael Walsh
Member of the US Advisory Board
75
Eamon Power
Non Executive Director
€43K
63
1.9 yrs
Wayne Seltzer
Member of The US Advisory Board
75
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (€) | Value (€) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 28. Mar 19 | Sell | Hugh McGuire | Individual | 28. Mar 19 | 28. Mar 19 | -14,989 | €17.39 | €-259,901 | ||
| 28. Mar 19 | Sell | Michael Horan | Individual | 28. Mar 19 | 28. Mar 19 | -4,718 | €17.29 | €-81,551 | ||
| 28. Mar 19 | Sell | Brian Phelan | Individual | 28. Mar 19 | 28. Mar 19 | -14,755 | €17.45 | €-256,344 | ||
| 28. Mar 19 | Sell | Siobhán Talbot | Individual | 28. Mar 19 | 28. Mar 19 | -14,842 | €17.29 | €-256,544 | ||
| 28. Mar 19 | Sell | Mark Garvey | Individual | 28. Mar 19 | 28. Mar 19 | -8,730 | €17.29 | €-150,898 | ||
| 11. Mar 19 | Sell | Hugh McGuire | Individual | 11. Mar 19 | 11. Mar 19 | -8,535 | €18.55 | €-158,324 | ||
| 11. Mar 19 | Sell | Michael Horan | Individual | 11. Mar 19 | 11. Mar 19 | -5,000 | €18.45 | €-92,250 | ||
| 11. Mar 19 | Sell | Brian Phelan | Individual | 11. Mar 19 | 11. Mar 19 | -8,082 | €18.54 | €-149,840 | ||
| 25. Jun 18 | Sell | Patrick Murphy | Individual | 25. Jun 18 | 25. Jun 18 | -21,692 | €17.84 | €-387,020 | ||
Management checks
We assess Glanbia's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Glanbia has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Did Glanbia plc (ISE:GL9) Insiders Sell Shares?
So we'll take a look at whether insiders have been buying or selling shares in Glanbia plc (ISE:GL9). … View our latest analysis for Glanbia Glanbia Insider Transactions Over The Last Year Over the last year, we can see that the biggest insider sale was by the Vice Chairman, Patrick Murphy, for €387k worth of shares, at about €17.84 per share. … Insider Ownership of Glanbia For a common shareholder, it is worth checking how many shares are held by company insiders.
Simply Wall St - – Full articleHow Glanbia plc's (ISE:GL9) Earnings Growth Stacks Up Against The Industry
View our latest analysis for Glanbia Did GL9 perform better than its track record and industry? … Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 10%, indicating the rate at which GL9 is growing has slowed down. … You should continue to research Glanbia to get a better picture of the stock by looking at: Future Outlook: What are well-informed industry analysts predicting for GL9’s future growth?
Simply Wall St - – Full articleHere's What You Should Know About Glanbia plc's (ISE:GL9) 1.5% Dividend Yield
Dividend paying stocks like Glanbia plc (ISE:GL9) tend to be popular with investors, and for good reason - some research shows that a significant amount of all stock market returns come from reinvested dividends. … Yet sometimes, investors buy a stock for its dividend and lose money because the share price falls by more than they earned in dividend payments. … Investors might not know much about Glanbia's dividend prospects, even though it has been paying dividends for the last nine years and offers a 1.5% yield.
Simply Wall St - – Full articleIs Glanbia plc's (ISE:GL9) High P/E Ratio A Problem For Investors?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … We'll apply a basic P/E ratio analysis to Glanbia plc's (ISE:GL9), to help you decide if the stock is worth further research. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleIs Glanbia plc (ISE:GL9) Investing Effectively In Its Business?
Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … Return On Capital Employed (ROCE): What is it? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleUpdate: Glanbia (ISE:GL9) Stock Gained 61% In The Last Five Years
To wit, the Glanbia share price has climbed 61% in five years, easily topping the market return of 39% (ignoring dividends). … During five years of share price growth, Glanbia achieved compound earnings per share (EPS) growth of 9.2% per year. … Rather, the share price has approximately tracked EPS growth.
Simply Wall St - – Full articleShould You Worry About Glanbia plc's (ISE:GL9) CEO Pay Cheque?
First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Siobhán Talbot's Compensation Compare With Similar Sized Companies. … Our data indicates that Glanbia plc is worth €5.0b, and total annual CEO compensation is €2.3m.
Simply Wall St - – Full articleWhat You Must Know About Glanbia plc's (ISE:GL9) Financial Strength
While they are less talked about as an investment category, mid-cap risk-adjusted returns have generally been better than more commonly focused stocks that fall into the small- or large-cap categories. … Today we will look at GL9’s financial liquidity and debt levels, which are strong indicators for whether the company can weather economic downturns or fund strategic acquisitions for future growth. … Note that this commentary is very high-level and solely focused on financial health, so I suggest you dig deeper yourself.
Simply Wall St - – Full articleGlanbia plc (ISE:GL9): What Does The Future Look Like?
In December 2018, Glanbia plc (ISE:GL9) released its latest earnings announcement, whicha … confirmed … business
Simply Wall St - – Full articleWant To Invest In Glanbia plc (ISE:GL9)? Here's How It Performed Lately
Below, I will assess GL9's latest performance announced on 29 December 2018 and weight these figures against its longer term trend and industry movements. … How Did GL9's Recent Performance Stack Up Against Its Past. … Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 10%, indicating the rate at which GL9 is growing has slowed down
Simply Wall St - – Full articleCompany Info
Description
Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, the Internet, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment operates as a milk processor in Ireland; and produces a range of value added dairy ingredients and consumer products. It also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, BSN, Isopure, Nutramino, ABB, thinkThin, Amazing Grass, Body & Fit, and SlimFast brands in approximately 100 countries. The company was founded in 1964 and is headquartered in Kilkenny, Ireland.
Details
| Name: | Glanbia plc |
| GL9 | |
| Exchange: | ISE |
| Founded: | 1964 |
| €4,643,092,509 | |
| 295,174,349 | |
| Website: | http://www.glanbia.com |
| Address: |
Glanbia plc Glanbia House, Ring Road, Kilkenny, Co. Kilkenny, Ireland |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| ISE | GL9 | Ordinary Shares | Irish Stock Exchange | IE | EUR | 02. Jan 1992 | |
| OTCPK | GLAP.F | Ordinary Shares | Pink Sheets LLC | US | USD | 02. Jan 1992 | |
| DB | GL9 | Ordinary Shares | Deutsche Boerse AG | DE | EUR | 02. Jan 1992 | |
| LSE | GLB | Ordinary Shares | London Stock Exchange | GB | EUR | 02. Jan 1992 | |
| BMV | GLB N | Ordinary Shares | Bolsa Mexicana de Valores | MX | MXN | 02. Jan 1992 | |
| BATS-CHIXE | GLBL | Ordinary Shares | BATS 'Chi-X Europe' | GB | EUR | 02. Jan 1992 | |
| BATS-CHIXE | GL9I | Ordinary Shares | BATS 'Chi-X Europe' | GB | EUR | 02. Jan 1992 | |
| OTCPK | GLAP.Y | SPONSORED ADR | Pink Sheets LLC | US | USD | 20. Oct 1998 |
Number of employees
Current staff
Industry
| Packaged Foods and Meats | |
| Food, Beverage & Tobacco |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/05/22 21:13 |
| End of day share price update: | 2019/05/22 00:00 |
| Last estimates confirmation: | 2019/04/26 |
| Last earnings filing: | 2019/02/27 |
| Last earnings reported: | 2018/12/29 |
| Last annual earnings reported: | 2018/12/29 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
